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Accepted 17 February 2012A 28-year-old, gravida 2, para 1, woman was referred to the
hospital at 22 weeks of gestation because of short limbs in the
fetus. Her husband was 29 years old. She and her husband
were non-consanguineous, and there was no family history of
skeletal dysplasias. Prenatal ultrasound at 22 weeks of gesta-
tion revealed a fetus with shortening and angulation of the
long bones and hypomineralization of the skull and bones
(Fig. 1). Fetal biometry showed a biparietal diameter of
5.24 cm (22 weeks), an abdominal circumference of 17.78 cm
(22 weeks) and micromelia. The lengths of the long bones
were measured as 2.55 cm (17 weeks), 2.56 cm (19 weeks),
2.49 cm (18 weeks), 2.63 cm (18 weeks), 2.45 cm (19 weeks)
and 2.39 cm (18 weeks), for femur, tibia, fibula, humerus,
radius and ulna, respectively. The ultrasound findings were
consistent with the diagnosis of osteogenesis imperfecta (OI)
type II. The pregnancy was subsequently terminated. Cyto-
genetic analysis revealed a karyotype of 46,XX, and molecular
analyses of the COL1A1 and COL1A2 genes revealed a de
novo heterozygous coding deletion and splicing mutation of
c.1035_1035þ2delTGT in exon 19 and intron 19 of the
COL1A2 gene that predicts p.Val345del and an altered splice* Corresponding author. Department of Obstetrics and Gynecology, Mackay
Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei, Taiwan.
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doi:10.1016/j.tjog.2012.04.031site of intron 19 and exon 19 skipping (Fig. 2). The parents did
not have such a mutation. Postnatal radiograph demonstrated
generalized osteopenia, decreased mineralization of bones,
and abnormal tubular bones with thin cortex and shafts, callus
formation and fractures (Fig. 3).
OI type II (OMIM 166210) is an autosomal dominant
perinatal lethal form of OI that is caused by heterozygous
mutation in COL1A1 (OMIM 120150) or COL1A2 (OMIM
120160), and is characterized by undermineralization; broad,
crumpled and shortened limbs; thin beaded ribs; bowing,
angulation or fractures of the long bones; normal appearing
hands; and deformable calvarium on prenatal ultrasound [1,2].
Mutations in COL1A2 are predominantly non-lethal (80%)
[1,2]. About 60% of reported COL1A2 mutations are missense
mutations that result in substitution for triple helical glycine
residues, and the rest are deletions, insertions or splicing
defects [2]. In a study of 59 subjects with OI type II and
mutations in the type I collagen genes, Bodian et al [2] found
that 37 had mutations in COL1A1 and 22 had mutations in
COL1A2. In their report, the 37 COL1A1 mutations included
26 with substitution for a glycine within the Gly-Xaa-Yaa
triplet domain of the triple helix, four with altered splice
sites, one with exon skipping form a deletion spanning coding
and intronic sequence, one with a deletion, one with a dupli-
cation, one with an altered single residue in carboxyl-terminal
propeptide and others; and the 22 COL1A2 mutations includedcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Prenatal ultrasound at 22 weeks of gestation shows (A) curved femur, (B) curved femurs, (C) hypomineralization of the skull and (D) curved tibia (arrow).
F¼ femur.
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triplet domain of the triple helix, four with deletions, two
with splice-site mutations, one with a duplication, one withFig. 2. Molecular analysis of the COL1A2 gene shows a de novo heterozygous
coding deletion and splicing mutation of c.1035_1035þ2delTGT in exon 19
and intron 19 of the COL1A2 gene in the fetus.a deletion spanning coding and intronic sequence, and one
with no resolution. Clinical reports of OI type II associated
with both a deletion mutation spanning coding and intronicFig. 3. Postnatal radiograph shows decreased mineralization of bones and
abnormal tubular bones with thin cortex and shafts, callus formation and
fractures.
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novo heterozygous coding and splicing deletion mutation of
c.1035_1035þ2delTGT in exon 19 and intron 19 of the
COL1A2 gene that predicts p.Val345del and exon 19 skipping.
Such a deletion mutation has been reported to be associated
with lethal OI. Pyott et al [3] reported a family with a mosaic
mother, two affected infants with lethal OI and a mutation of
c.1035_1035þ2delTGT in the COL1A2 gene.
The present case had a mutation at splice donor site. Marini
et al [1] found that in COL1A1 splice-site mutations, muta-
tions at donor sites are equal to mutations at acceptor sites,
whereas in COL1A2 splice-site mutations, mutations at donor
sites are four times more common than mutations at acceptor
sites. Marini et al [1] reported 11 lethal COL1A2 splice-site
mutations, and all were located in the carboxyl half of the
chain, of which ten cases involved exon skipping (exons 28,
30, 32, 33, 34, 37, 42 and 47) and one involved an in-frame
deletion in exon 40. Bodian et al [2] reported four lethal
COL1A2 splice-site mutations involving exon skipping (exons
29, 30, 41 and 46). Pyott et al [3] reported three lethal
COL1A2 splice-site mutations involving exon skipping (exons
19, 32 and 35). The present case adds to the list of lethal
COL1A2 splice-site mutations and provides evidence thata COL1A2 splice-site mutation involving exon 19 skipping can
be lethal.
Acknowledgments
This work was supported by research grants NSC-97-2314-
B-195-006-MY3 and NSC-99-2628-B-195-001-MY3 from the
National Science Council, and MMH-E-100-04 from Mackay
Memorial Hospital, Taipei, Taiwan.
References
[1] Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD,
Milgrom S, et al. Consortium for osteogenesis imperfecta mutations in the
helical domain of type I collagen: regions rich in lethal mutations align
with collagen binding sites for integrins and proteoglycans. Hum Mutat
2007;28:209e21.
[2] Bodian DL, Chan T-F, Poon A, Schwarze U, Yang K, Byers PH, et al.
Mutation and polymorphism spectrum in osteogenesis imperfecta type II:
implications for genotype-phenotype relationships. Hum Mol Genet 2009;
18:463e71.
[3] Pyott SM, Pepin MG, Schwarze U, Yang K, Smith G, Byers PH. Recur-
rence of perinatal lethal osteogenesis imperfecta in sibships: parsing the
risk between parental mosaicism for dominant mutations and autosomal
recessive inheritance. Genet Med 2011;13:125e30.
